Related Experiment Video
Updated: Jan 31, 2026

Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
Biocatalytic Tetrapeptide Macrocyclization by Cryptic Penicillin-Binding Protein-Type Thioesterases
Paisley L Jeannette1, Zachary L Budimir1, Lucas O Johnson1
1James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, Indiana 47906, United States.
Researchers discovered WP516, a novel thioesterase enzyme, using bioinformatics. This enzyme efficiently cyclizes various tetrapeptides, expanding possibilities for producing cyclic tetrapeptides (CTPs).
Area of Science:
- Biochemistry
- Bioinformatics
- Natural Product Synthesis
Background:
- Cyclic tetrapeptides (CTPs) are valuable natural products with diverse bioactivities.
- Synthesizing CTPs is challenging due to ring strain and limitations of current chemical methods.
- Enzymatic approaches for CTP synthesis are sought after for broader substrate scope.
Purpose of the Study:
- To discover novel enzymes for efficient tetrapeptide cyclization using a bioinformatics-guided approach.
- To identify and characterize a thioesterase enzyme capable of producing diverse cyclic tetrapeptides.
- To understand the mechanism behind the enzyme's broad substrate specificity.
Main Methods:
- Bioinformatic analysis of cryptic nonribosomal peptide synthetase (NRPS) gene clusters.
- In silico prediction and identification of penicillin-binding type thioesterases (PBP-TEs).
- Biochemical characterization of the identified enzyme (WP516) with various tetrapeptide substrates.
- Structural and computational analyses including AlphaFold modeling, covalent docking, molecular dynamics, and mutational studies.
Main Results:
- The first bioinformatics-guided discovery of a thioesterase (WP516) for peptide cyclization from a cryptic gene cluster.
- WP516 demonstrates efficient cyclization of a wide range of tetrapeptide substrates.
- WP516 exhibits a significantly broader substrate scope compared to the previously known tetrapeptide cyclase Ulm16.
- Structural and computational analyses provided insights into WP516's broad substrate acceptance.
Conclusions:
- The developed bioinformatics workflow is effective for discovering novel enzymes involved in peptide cyclization.
- WP516 is a powerful biocatalyst for the production of diverse head-to-tail cyclic tetrapeptides.
- This discovery offers a new strategy for enzyme discovery in peptide cyclization and biocatalytic CTP production.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The Equilibrium Binding Constant and Binding Strength
Drug Distribution: Plasma Protein Binding
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding and Linkage

